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Microgela b s t r a c t
Microgels are interesting as potential delivery systems for antimicrobial peptides. In order to elucidate
membrane interactions of such systems, we here investigate effects of microgel charge density on antimi-
crobial peptide loading and release, as well as consequences of this for membrane interactions and
antimicrobial effects, using ellipsometry, circular dichroism spectroscopy, nanoparticle tracking analysis,
dynamic light scattering and z-potential measurements. Anionic poly(ethyl acrylate-co-methacrylic acid)
microgels were found to incorporate considerable amounts of the cationic antimicrobial peptides LL-37
(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) and DPK-060 (GKHKNKGKKNGKHNGWKWWW) and to
protect incorporated peptides from degradation by infection-related proteases at high microgel charge
density. As a result of their net negative z-potential also at high peptide loading, neither empty nor
peptide-loaded microgels adsorb at supported bacteria-mimicking membranes. Instead, membrane dis-
ruption is mediated almost exclusively by peptide release. Mirroring this, antimicrobial effects against
several clinically relevant bacteria (methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli,
and Pseudomonas aeruginosa) were found to be promoted by factors facilitating peptide release, such
as decreasing peptide length and decreasing microgel charge density. Microgels were further demon-
strated to display low toxicity towards erythrocytes. Taken together, the results demonstrate some inter-
esting opportunities for the use of microgels as delivery systems for antimicrobial peptides, but also
highlight several key factors which need to be controlled for their successful use.
 2017 Elsevier Inc. All rights reserved.
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Due to increasing resistance against conventional antibiotics,
antimicrobial peptides (AMPs) have received considerable atten-
tion as potential therapeutics. Although AMPs affect bacteria in
numerous ways, their main mode of action is through direct mem-
brane rupture, providing them with fast and broad-spectrum
antimicrobial effects [1–3]. Through various approaches, such as
combinatory library approaches [4], quantitative structure-
activity relationship studies [5,6], identification of endogenous
peptides derived from infection-related proteolysis [7], and end-
tagging with short tryptophan or phenylalanine stretches [8],
AMPs have been designed to display high potency, also against
demanding (e.g., antibiotics-resistant) bacteria, yet displaying
low toxicity against human cells. In addition to direct antimicrobial
effects, some AMPs also display other host defense properties,
including anti-inflammatory [2,9] and anticancer [10] effects.
These effects are again depending on AMP interactions with
membranes and membrane components, but involving also other
mechanisms, such as macrophage uptake and resulting clearance
in the case of anti-inflammatory effects [11], and apoptosis
induction in the case of anti-cancer effects [10].
In contrast to the considerable interest that has been devoted to
improving AMP potency and selectivity, drug delivery aspects of
AMPs have been much less investigated. Yet, AMPs suffer from sev-
eral challenges in the context of drug delivery, which have to be
resolved for AMP therapeutics to reach their full potential. Thus,
with the exception of AMPs specifically designed to display stabil-
ity [8], proteolytic degradation in infected tissue will dramatically
reduce the effect of AMPs administered unformulated, e.g., for cys-
tic fibrosis airways, infected mucosal surfaces, or chronic wounds.
Here, drug delivery systems may offer approaches for protection of
AMPs against proteolytic degradation until they have reached their
site of action [12,13]. Furthermore, due to their net positive charge
and amphiphilicity, AMPs bind to net anionically charged serum
proteins, resulting in rapid clearance from bloodstream circulation
and accumulation in the reticuloendothelial system [14,15]. Here,
delivery systems may reduce such serum protein binding, as well
as scavenging-related activity loss. Delivery systems may also
facilitate cell internalization of AMPs, potentially leading to their
co-localization with internalized pathogens (important, e.g., for
tuberculosis), allowing action of the intracellular bacteria without
having to lyse the host macrophages [16]. Furthermore, sustained
or triggered AMP release may be of interest, such as for implants
or depot formulations against recurring infection. Also here, deliv-
ery systems could potentially offer functional advantages for AMP-
based therapies [17,18].
Various types of nanomaterials may offer opportunities as
delivery systems for AMPs [19], including self-assembly systems
formed by surfactants, (block co)polymers, and polar lipids
[20–22], polymer (micro)gels [23–25] as well a wide range of inor-
ganic nanoparticles/nanomaterials [12,26–28], each offering
system-specific opportunities. Within the present investigation,
focus was directed towards microgels as delivery systems for
AMPs, as these have previously been demonstrated to be powerful
delivery systems for peptides, as well as of other biomacromolec-
ular drugs, including proteins, siRNA, and DNA [29]. Microgels/
nanogels are lightly cross-linked polymer colloids, which can be
designed to display dramatic swelling/de-swelling in response to
various parameters, such as temperature, pH, and ionic strength.
In addition, microgels/nanogels can be remotely triggered through
external fields, such as near-infrared radiation or light, as well as
magnetic field. The responsiveness can also be tuned so that the
gels release their cargo on more specific stimuli to certain diseases,
e.g., microgels releasing insulin in response to increasing glucoseconcentration [30], or gels that releases antibiotics in response to
bacterial proteases [31].
In order to elucidate key properties of AMP-loaded microgels,
we here investigate effects of microgel charge density on AMP
loading and release for poly(ethyl acrylate-co-methacrylic acid)
microgels of different charge density [32], using a method combi-
nation of ellipsometry, circular dichroism spectroscopy, nanoparti-
cle tracking analysis, dynamic light scattering, and z-potential
measurements. In addition, membrane interactions of peptide-
loaded microgels are addressed, and the result correlated to func-
tional consequences, including antimicrobial activity, hemolysis,
and proteolytic stability.2. Materials and methods
2.1. Materials
Peptide AP114 (GFGCNGPWNEDDLRCHNHCKSIKGYKGGY
CAKGGFVCKCY, purity 99.1%) was provided by Adenium Biotech
ApS (Copenhagen, Denmark), while DPK-060 (GKHKNKGKKNG
KHNGWKWWW, purity 98.5%), was synthesized by Bachem AG
(Bubendorf, Switzerland) and provided by Pergamum AB
(Stockholm, Sweden), LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLR
NLVPRTES, purity 94.7%) was synthesized and provided by
PolyPeptide Laboratories (Limhamn, Sweden) and poly-L-lysine
(150 kDa, >90% purity) was obtained from Sigma Aldrich
(Schnelldorf, Germany). More information on the properties of
the antimicrobial peptides used can be found in Table S1, Support-
ing Information. Lipids DOPE (1,2-dioleoyl-sn-Glycero-3-phos
phooethanolamine) and DOPG (1,2-dioleoyl-sn-Glycero-3-phos
phglycerol, monosodium salt) (both >99% purity) were obtained
from Avanti Polar Lipids (Alabaster, USA). Escherichia coli (E. coli)
ATCC 25922 was obtained from the American Type Culture Collec-
tion, as was Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853,
whereas Methicillin resistant Staphylococcus aureus (MRSA; clinical
strain 0702E0196) and Pseudomonas aeruginosa (clinical strain
0704C0134) were isolated from patients at CHU, Angers. Brain-
heart infusion (BHI) broth was purchased from bioMérieux (Marcy
l’Etoile, France), while Columbia agar plates supplemented with
sheep blood were obtained from Oxoid (Dardilly, France). Purified
Milli-Q water was used throughout. All other chemicals used were
of analytical grade and obtained from Sigma-Aldrich (Schnelldorf,
Germany).2.2. Microgel synthesis
Poly(ethyl acrylate-co-methacrylic acid) or poly(ethyl acrylate
(EA)/methacrylic acid (MAA)/1,4-butandiol diacrylate (BDDA))
microgels were prepared through seed-feed (starved feed) emul-
sion polymerization, reported by Rodriguez et al. [33]. The compo-
sition of the monomer emulsion feed in w/w was varied to obtain
gels with different electrostatic driving forces for peptide adsorp-
tion, here either 72.5/26.5/1 or 39/60/1 (EA/MAA/BDDA) w/w
was used. Henceforth, microgels are abbreviated according to
w/w methacrylic acid content in the feed solution. Titration
experiments showed MAA26.5 and MAA60 microgels to have a
methacrylic acid content of 34.3 ± 1.1 and 63.3 ± 1.5% w/w, respec-
tively (Table S2, Supporting Information). In the synthesis process,
31.5 g (of the total 260 g) EA/MAA/BDDA monomer mixture was
added as a seed to a nitrogen-purged solution consisting of 1.8 g
SDS in 517.5 g H2O under stirring in a four-necked, round-
bottom flask at 80 C. This was immediately followed by addition
of dipotassium hydrogen phosphate (3 g of a 7.7 wt% aqueous solu-
tion) and ammonium persulfate (APS, 3.6 g of 5 wt%). After 30 min,
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min) over 90 min. To achieve a similar size range of the microgel
systems, a second initiator step (3.2 g of 3 wt% APS) was included
in the case of MAA26.5 microgels. During the polymerization pro-
cess, the size of the microgels was regularly sampled and measured
with photon correlation spectroscopy using a BI-9000 Brookhaven
light scattering apparatus (Brookhaven Instrument Cooperation,
NY, USA), fitted with a 20 mW HeNe laser and the detector set at
a 90 scattering angle. When reaching the desired size (100 nm
diameter), the reaction was stopped by cooling, after which the
microgel solution was extensively dialyzed against water.
2.3. Surface preparation and microgel deposition
Silica substrates used were either glass coverslips, 0.16–0.19
mm thickness (Fisher Scientific, Gothenburg, Sweden), or prepared
from polished silicon wafers, oxidized to an oxide layer thickness
of 30 nm (Semiconductor Wafer Inc., Hsinchu, Taiwan). The result-
ing silica substrates were cleaned, first in 25% NH4OH, 30% H2O2,
and H2O (1:1:5, w/w), followed by 25% HCl, 30% H2O2, and H2O
(1:1:5, w/w), both at 80 C for 5 min. The surfaces were subse-
quently washed thoroughly in water and ethanol (99.7%). Samples
were then functionalized with (3-glycidyloxypropyltrimethoxysi
lane (GOPS) to enable microgel immobilization to the surfaces
using a slightly modified previously reported protocol by Wong
et al. [34]. In short, surface silanol groups were reacted with GOPS,
providing a chemical handle for carboxyl functionalities on the
microgels to attach to by forming ester bonds. This methodology
is well established in literature for covalent reactions, both in gen-
eral and for covalent reactions in surface modifications [35]. The
clean surfaces were placed in dry glassware under N2 (g). Dry
toluene (400 mL), GOPS (100 mL), and Hünig’s base (3 mL) was
added under N2 (g). The reaction was refluxed at 110 C for 24 h.
Upon completion, the surfaces were sonicated twice for 15 min
in methanol, and subsequently rinsed with dichloromethane fol-
lowed by diethyl ether. The functionalized substrates were imme-
diately submerged in 0.1% w/w microgel solution, pH 5.1, and
incubated overnight at 50 C. Unbound microgels were rinsed off
and samples stored in water until further use.
2.4. Microgel size and charge
Size determination of microgels at different peptide loading was
investigated by nanoparticle tracking analysis (NTA), using a Nano-
Sight NS500 (NanoSight Ltd., Amesbury, UK), equipped with a
75 mW laser at 532 nm, and NTA 2.3 analytical software. Within
an illumination device mounted under a microscope, particles
passing through the beam path were visualized and measured.
From the particle displacements, diffusion coefficients of
individual particles were obtained, and the size subsequently
calculated from the Stokes-Einstein equation. A gel solution with
concentration 109 particles/mL was prepared in filtered Tris
(10 mM, pH 7.4) (Whatman Anotop 25, GE Healthcare, Little Chal-
font, UK). Peptide (LL-37 or DPK-060) was added to obtain concen-
trations in the range 0–1 µM. The samples were subsequently
mixed at 5 C overnight to reach saturation and kept cold until
measurement. Each concentration was run in triplicate for each
combination of gel and peptide. Each sample was run 10 times
and the results were pooled into one graph that was fitted using
PeakFit v4.12 (SeaSolve Software Inc., Framingham, USA).
Microgel z-potential with and without peptide was determined
using a Zetasizer Nano ZSP (Malvern Instruments, Malvern, UK) at
a scattering angle of 173. Peptide (0–100 µM) and gel (100 ppm)
samples in Tris (10 mM, pH 7.4) were mixed at 5 C overnight.
Analyses were performed at 25 C in triplicates n = 10, for each
sample.2.5. CD spectroscopy
Circular dichroism (CD) spectra were measured by a Jasco J-810
Spectropolarimeter (Jasco, Easton, USA). Measurements were per-
formed in duplicate at 37 C in a 10 mm quartz cuvette under stir-
ring with a peptide concentration of 10 µM in Tris (10 mM, pH 7.4),
either in the absence or presence of microgels at 333 ppm. The CD
signal at 225 nm was used to calculate the a-helix content, using
100% a-helix and 100% random coil references obtained from
0.133 mM (monomer concentration) poly-L-lysine (Mw = 79 kDa)
in 0.1 M NaOH and 0.1 M HCl, respectively. To account for instru-
mental differences between measurements, background correction
was performed routinely by subtraction of the buffer spectra of the
corresponding samples in the presence of peptide.
2.6. Liposome leakage
Anionic (DOPE/DOPG 75/25 mol/mol) model liposomes were
investigated, frequently used as bacteria membrane models [36].
To obtain lipid films, lipids were dissolved in chloroform (13
mM) and mixed in the desired ratio, after which chloroform was
carefully evaporated (rotaevaporation at 60 C for 45 min, followed
by vacuum oven overnight at room temperature). The films were
subsequently re-dispersed in Tris (10 mM, pH 7.4), also containing
0.1 M carboxyfluorescein (CF) and 5 mM glucose, to a lipid concen-
tration of 6 mM. The solution was subjected to eight freeze (N2 (l))-
thaw (60 C) cycles and subsequently extruded (LipoFast, Avestin,
Ottawa, USA) through 100 nm polycarbonate filters 30 times.
Untrapped CF was removed by gel filtration (Sephadex G-50, GE
Healthcare, Uppsala, Sweden) with Tris (10 mM, pH 7.4) as eluent.
Liposomemembrane disruption was monitored for samples at 520
nm in a SPEX-fluorolog 1650 0.22-m double spectrometer (SPEX
Industries, Edison, USA) at 37 C for 30 min. An absolute leakage
scale was obtained by disrupting the liposomes at the end of the
experiment by adding 0.8 mM Triton X-100 (Sigma-Aldrich, St.
Louis, USA). Measurements were performed in duplicates.
2.7. Ellipsometry
Peptide adsorption to microgel-coated silica wafers (prepared
as described above), as well as microgel/AMP interaction with
DOPE/DOPG bilayers on silica surfaces was studied in situ by null
ellipsometry, using an Optrel multiskop ellipsometer (Optrel,
Kleinmachnow, Germany) equipped with a 100 mV Ar laser.
Measurements were carried out at 532 nm and an angle of
incidence 67.66 in a 5 mL cuvette under stirring (300 rpm). In
brief, the mean refractive index (n) and thickness (d) of a layer at
the surface can be obtained by monitoring the state of polarization
of light reflected either with or without peptide in the case of
microgels at the surface or peptide adsorption to or lipid desorp-
tion from lipid bilayers The mass change (adsorption/desorption)
at the surface can then be calculated from
C ¼ ðn n0Þ
dn=dc
 d
where n0 is the refractive index of the bulk solution and dn=dc is the
refractive index increment (taken to be 0.154 cm3/g). Peptide
loading was studied on microgel-coated silica wafers in Tris-HCl
(10 mM, pH 7.4). Peptide binding to the microgels were measured
by step-wise addition of peptide to the cuvette (0.5, 3.75, 7.5, 15,
30, 60, 80 µM), allowing adsorption to reach saturation for at least
45 min before next addition. All samples were run in duplicate.
For studies of the interaction of peptide-loaded microgels with
DOPE/DOPG bilayers, the latter were prepared as described for
liposome leakage, but with some modification: (i) Tris (10 mM,
Fig. 1. Microgel de-swelling upon addition of LL-37 or DPK-060 to MAA26.5 or
MAA60 microgels in Tris (10 mM, pH 7.4).
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Tris (10 mM, pH 7.4), (ii) after extrusion through 100 nm filters, a
second extrusion through 30 nm filter was performed, and (iii)
no PD-10 column was used. In order to avoid adsorption of peptide
directly at the silica substrate through any defects of the supported
lipid layer (surface potential 40 mV, contact angle <10) [37]
poly-L-lysine (150 kDa) was pre-adsorbed from water prior to lipid
addition to an amount of 0.045 ± 0.01 mg/m2, followed by removal
of non-adsorbed poly-L-lysine by rinsing with water at 5 mL/min
for 20 min [38,39]. Water in the cuvette was then replaced by Tris
(10 mM, pH 7.4), which was followed by addition of liposomes in
buffer at a lipid concentration of 20 µM and subsequent rinsing
with Tris (10 mM, pH 7.4, with 150 mM NaCl) at 5 mL/min for
15 min when the liposome adsorption had stabilized in order to
remove non-adsorbed and weakly adsorbed liposomes. Subse-
quently, peptide-loaded microgels were added at a concentration
of 10 ppm microgel with and without 0.3 µM peptide respectively,
and the adsorption was monitored over 1 h, followed by rinsing
with Tris (10 mM, pH 7.4, with 150 mM NaCl) at 1 mL/min for
30 min and 5 mL/min for an additional 30 min. Duplicate measure-
ments were performed throughout.
2.8. Scanning electron microscopy (SEM) analysis
Gel covered silica wafers were prepared as described above. The
surfaces were dried in vacuum and stored under Ar (g). Samples
were sputtered with 5 nm platinum before imaging. SEM images
were obtained via a Hitachi S-4300 FE-SEM (Tokyo, Japan) at 3 kV.
2.9. Antimicrobial effects
Peptide-microgel formulations were incubated overnight under
shaking. Colonies (1–2) were taken directly from Columbia agar
plates into 2 ml of 0.85% NaCl solution, and the density of the
microorganism suspension adjusted to equal 1.1 McFarland stan-
dard (approximately 3.3  108 cfu/mL, MRSA) or 0.5 McFarland
standard (1.5  108 cfu/mL, P. aeruginosa, E. coli). The bacterial
suspensions were further diluted 100 (3.3  106 cfu/mL) or 10
(1.5  107 cfu/mL) times with BHI (AP-114) or water/BHI 100:1
(DPK-060 and LL-37), respectively. An amount of 100 lL of bacte-
rial suspension in BHI or water/BHI 100:1 was added into each well
of a sterile 96 well plate already containing 100 lL of peptide, gel
or gel-peptide sample. Positive control wells, containing BHI or
water/BHI 100:1, and the bacterial suspension without the tested
sample (growth control), as well as negative control wells, contain-
ing BHI or water/BHI 100:1 and the tested sample without the bac-
terial suspension (sterility control) were also prepared. The plates
were incubated at 37 C for 24 h. The minimal inhibitory concen-
tration (MIC) was defined as the lowest concentration of the sam-
ple that completely inhibited the growth of the bacteria as
detected by the unaided eye. If the assessment was not possible
due to the turbidity of the sample, an amount of approximately
2 lL was withdrawn from each well, transferred onto a plate with
Mueller Hinton agar using an AQS multipoint inoculator and incu-
bated for 24 h at 37 C. Values reported were determined from
triplicate experiments.
2.10. Proteolytic stabilization
Peptide (2 µg) or peptide-microgel formulations were incubated
at 37 C with P. aeruginosa elastase (PE, 0.2 lg, 25000 units/mg)
(BioCol GmbH, Potsdam, Germany) in a total volume of 15 lL of
Tris (10 mM, pH 7.4) for 16 h. The materials were placed on
10–20% precast Tris-Tricine sodium dodecyl sulfate polyacry-
lamide (SDS-PAGE) Tris-Tricine gels (Invitrogen) and analyzed
after staining with Coomassie Brilliant Blue. Quantification of bandintensities, from triplicate measurements, was performed by
Molecular Imager Gel DOC with Image Lab Software (BioRad, Her-
cules, USA).2.11. Hemolysis
EDTA-blood was centrifuged at 800g for 10 min, and plasma
and buffy coat removed. Erythrocytes were washed three times
and re-suspended in 5% PBS, pH 7.4. The cells were then incubated
with end-over-end rotation for 1 h at 37 C in the presence of
microgels with or without peptide at the indicated concentrations.
For comparison, 2% Triton X-100 (Sigma-Aldrich, St. Louis, USA)
served as positive control. The samples were then centrifuged at
800g for 10 min. The hemoglobin release was measured by absor-
bance at 550 nm and is expressed as% of Triton X-100-induced
hemolysis (n = 3).3. Results
3.1. Peptide loading and release
As a consequence of loading of net positively peptide into the
negatively charged microgels, the latter display pronounced osmo-
tic de-swelling, as demonstrated for both LL-37 and DPK-060
(Fig. 1). Quantitatively, both MAA26.5 and MAA60 display drastic
de-swelling even at low DPK-060, reaching limiting collapse at
the lowest concentration used, i.e., at a peptide concentration of
0.0001 µM for a microgel concentration of 108 microgels/mL
(600 peptides/microgel particle, assuming complete peptide
binding). For LL-37, both microgels display a more gradual
de-swelling with increasing LL-37 concentration. Furthermore,
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lower LL-37 concentration than the lower charged MAA26.5.
Together, the particle size results thus indicate that while electro-
static interactions are important for peptide loading into the
microgels, this also varies between different AMPs, the smaller
and slightly higher charged DPK-060 inducing more pronounced
de-swelling on microgel loading.
Despite the importance of electrostatic interactions for peptide
loading, however, the z-potential of the loaded microgels unex-
pectedly only changes marginally upon peptide loading up to a
peptide concentration of 100 µM (Fig. 2a). Nevertheless, peptide
loading results in the formation of oligomers for both microgels,
but somewhat more extensively so for DPK-060 (Figs. 2b and S1,
Supporting Information). This indicates that the microgel
z-potential is dictaded by dilute negatively charged tails, the repul-
sive barrier is partially overcome after peptide loading as a result of
van der Waals interactions (increasing with microgel de-swelling)
and potentially also by positively charged patches on the microgel
particles.
To quantify peptide loading and binding kinetics further,
microgel-covered silica wafers were prepared at a surface coverage
of 10–15% (3–5  1013 microgel particles/m2) (Fig. 3a and b). As
seen in Fig. 3c, ellipsometry shows that background adsorption of
the peptides investigated to the underlying surface was quite
limited, allowing quantification of peptide loading to the surface-Fig. 2. (a) Z-potential of MAA26.5 and MAA60 microgels in the absence and
presence of either LL-37 or DPK-060 at the indicated concentration in Tris (10 mM,
pH 7.4). The microgel concentration used was 100 ppm. (b) Fraction of peptide-
loaded microgel particles in monomer state. The microgel concentration used was
108 particles/mL in Tris (10 mM, pH 7.4).bound microgels. From this, it was found that the surface-bound
microgels are able to incorporate considerable amounts of peptide,
and that binding displayed high affinity behavior, followed by
more gradual binding at higher peptide loads (Fig. S2, Supporting
Information). Furthermore, saturation binding of LL-37 and DPK-
060 is quite similar, in both cases increasing somewhat with
increasing microgel charge density.
Following saturation, ellipsometry showed peptide release to be
quite limited within the time-frame investigated (2 h) in Tris (10
mM, pH 7.4), for both peptides, whereas peptide release increased
in the additional presence of 150 mM NaCl, particularly so for the
shorter DPK-060 peptide (Fig. 4). Peptide release was previously
found to depend on peptide length [40], net charge, charge distri-
bution, and mean hydrophobicity [41]. It was found that localized
charges suppress peptide released due to a locally high charge den-
sity, whereas peptide release is facilitated by evenly distributed
charges. The present results are in line with these previous find-
ings, as both LL-37 and DPK-060 have quite evenly distributed
charges, but LL-37 being substantially longer of the two peptides,
thus decreasing its electrolyte-induced release.
As a result of microgel incorporation, LL-37 undergoes consider-
able conformational changes, from a disordered random coil con-
formation in aqueous solution, to display pronounced helix
formation after microgel incorporation, in analogy to the propen-
sity displayed by this peptide for helix formation after binding to
both anionic phospholipid membranes and anionic polysaccha-
rides [42]. Quantitatively, the helix content after microgel binding
is independent of gel charge density (Fig. 5). In contrast to the pro-
nounced helix induction observed for LL-37, DPK-060, previously
demonstrated to undergo only limited conformational changes
on anionic complexation [8], displays a largely disordered struc-
ture also after microgel incorporation, again independent of micro-
gel charge density in the range investigated (Fig. 5).
3.2. Membrane interactions
Next, the interaction of MAA26.5 and MAA60 microgels with
DOPE/DOPG supported bilayers was investigated. As seen in
Fig. 6, the MAA26.5 and MAA60 microgels, both having a z-
potential of z  30 mV, displayed limited binding to the similarly
net negatively charged DOPE/DOPG bilayers (35 mV), indepen-
dent of microgel concentration in the range 1–1000 ppm. Pre-
loading the microgels (at a 10 ppm concentration) with LL-37 or
DPK-060 at 0.3 lM resulted in some adsorption to the DOPE/DOPG
bilayer in the case of LL-37 but less so for DPK-060. Mirroring the
lack of adsorption of peptide-void microgels, neither MAA26.5 nor
MAA60 caused any liposome leakage induction in DOPE/DOPG
liposomes in low ionic strength, up to a microgel concentration
of 100 ppm, whereafter some, relatively minor, leakage induction
is observed (Fig. 7a). Furthermore, the potent membrane disrup-
tion observed for both DPK-060 and LL-37 in solution is essentially
lost after incorporation into MAA26.5 or MAA60 microgels (Fig. 7b)
in Tris (10 mM, pH 7.4), demonstrating peptide localization into
the interior of the microgels, in agreement with the absence of
adsorption to supported DOPE/DOPG bilayers at low ionic
strengths, as well as the net negative z-potential of the peptide-
loaded microgels. Similar effects on liposome leakage and z-
potential were observed also for the antimicrobial peptide
AP114, as were effects on z-potential for Polymyxin B and poly-L-
lysine upon incorporation into microgels (results not shown),
demonstrating the generality of these effects for different peptides.
After allowing peptide-loaded microgels to release their peptide
cargo at higher ionic strength overnight, however, membrane dis-
ruption capacity is partially restored, an effect more pronounced
for the lower charged MAA26.5 microgels (Fig. 8). Therefore, the
membrane-disrupting effect seen for these systems is caused by
Fig. 3. (a) Representative SEM images of silicon wafers coated with MAA26.5 (left) and MAA60 (right). For both microgels, the gel coverage, batch-to-batch variation included,
is 10–15%. (b) The immobilized microgel particles display a wide distribution in size, but are in both cases centered around 70 nm. (c) Saturation binding of LL-37 and DPK-
060 to MAA26.5 and MAA60 microgels immobilized on silica substrates from Tris (10 mM, pH 7.4). Background adsorption at the underlying substrate, in the absence of
surface-bound microgels, is indicated as well.
Fig. 4. Ellipsometry results on desorption of microgel-loaded peptides in Tris (10
mM, pH 7.4), with or without additional 150 mM NaCl. Before rinsing, the surface-
bound microgels were allowed to reach maximum peptide loading, and stabilize for
2 h. Surfaces were then rinsed at 1 ml/min in a 3 mL cuvette for 2 h under stirring.
Increasing the ionic strength triggered peptide release from the microgels.
Fig. 5. Circular dichorism spectra (top) and helix content (bottom) of 10 µM LL-37
and DPK-060 before and after peptide loading to MAA26.5 and MAA60 microgels
(333 ppm) in Tris (10 mM, pH 7.4).
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a peptide-loaded gel.
3.3. Antimicrobial effects
Having clarified the membrane interactions of the MAA26.5 and
MAA60 microgels in the absence and presence of antimicrobial
peptide incorporation, we next investigated how the observations
made with the model lipid membranes correlated to experiments
on bacteria strains. In line with the ellipsometry and liposome
leakage results, in vitro studies on Gram-negative E. coli, and P.
aeruginosa, and Gram-positive MRSA showed that neither
MAA26.5 nor MAA60 display bactericidal effect on its own, MIC
being above 100 ppm, the highest microgel concentration investi-
gated (Table 1). Furthermore, antimicrobial effects of DPK-060
were found to be promoted by decreasing microgel charge density,
reflecting the faster peptide release of this peptide from MAA26.5
microgels. Quantitatively, the latter resulted in MIC values compa-
rable to that of the free peptide on E. coli and MRSA. In the case ofthe two P. aeruginosa strains, an improved MIC was observed for
the DPK-060-loaded MAA26.5-microgels. For LL-37, displaying
slower peptide release, on the other hand, microgel incorporation
resulted in a pronounced increase in MIC, reflecting microgel
encapsulation of the peptide not released.
Fig. 6. Normalized microgel binding to supported DOPE/DOPG bilayers in Tris (10
mM, pH 7.4) (above). Relative adsorption change, after bilayer mass normalization,
upon addition of MAA26.5 or MAA60 microgels (10 ppm) loaded with LL-37 and
DPK-060 at 0.3 lM in Tris (10 mM, pH 7.4) (below). Values reported represent
limiting net adsorption differences after 1 h incubation with the bilayer in Tris (10
mM, pH 7.4). For comparison, data obtained for free peptide are included as well.
Fig. 7. Leakage of DOPE/DOPG liposomes upon incubation with MAA26.5 and MAA60 m
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Mirroring the low membrane affinity of empty MAA26.5 and
MAA60microgels, as well as of the corresponding microgels loaded
with LL-37 and DPK-060, hemolysis is quite low. Hemolysis shows
low erythrocyte destabilization of the empty microgels, close to
the negative control, up to microgel concentrations of 100 ppm
(Fig. 9a). For microgels loaded with DPK-060, the hemolysis is
comparable to that of the free peptide (Fig. 9b), whereas incorpo-
rating LL-37 into microgels significantly decreases the hemolysis
caused by this peptide, the latter effect slightly more pronounced
for the more highly charged MAA60 microgels.
3.5. Proteolytic stabilization
Finally, we note that incorporation into MAA60 offers protec-
tion of LL-37 against proteolytic degradation by infection-related
enzymes from bacteria (P. aeruginosa elastase, PE) (Fig. 10). This
is in line with the preferential localization of LL-37 within the
microgel particles, demonstrated above, and limited access for
the relatively large PE enzymes into the small pores. In contrast,
the less charged MAA26.5 microgels do not offer such protection
against proteolytic degradation.
4. Discussion
Although microgels have been found to offer advantages as
delivery agents of biomacromolecular drugs, including peptides,
proteins, DNA, and siRNA [43,44], and although peptide loading
and release to/from microgels have been shown to depend on fac-
tors such as peptide length [45], hydrophobicity (distribution) [46],
charge (distribution) [41], and secondary structure [47], as well as
on biodegradation of both peptide [48], and microgel [49], studies
of the use of microgels/nanogels as AMP carriers are relativelyicrogels (10 ppm) in the absence (a) or presence of either LL-37 (b) or DPK-060 (c).
Fig. 8. Comparison between liposome leakage for free peptide at 0.3 µM, with and
without 10 ppm MAA26.5 or MAA60. Results are plotted as the difference between
leakage at high (Tris 10 mM with 150 mM NaCl) – low (10 mM Tris) ionic strength.
A positive value means increased effect at physiological electrolyte concentration.
As seen, enhanced membrane disruption is observed for the microgel/peptide
systems due to electrolyte-induced peptide release, whereas free peptide in
absence of microgel display partial inactivation at high ionic strength.
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novicidin (KNLRRIIRKGIHIIKKYF) in hydrophobically-modified
hyaluronic acid-based microgels, and found that both encapsula-
tion efficiency and z-potential could be tuned by changing the
preparation parameters, reaching a maximum peptide load of
36%. The microgels were found to display good colloidal stability
and complete peptide release over 14 days. Furthermore, binding
of novicidin to the hyaluronic acid microgels significantly reduced
peptide toxicity against HUVECs and NIH 3 T3 cells, while showing
no loss of antimicrobial activity against E. coli and S. aureus [50].
These results are partly in line with those found presently for LL-
37 and DPK-060 in poly(ethyl acrylate-co-methacrylic acid) micro-
gels, particularly in relation to the long release time of net posi-
tively charged AMPs from negatively charged microgels, and
regarding the high peptide drug loading reachable with such
microgel systems. Having said that, we also note some differences,
notably an onset of microgel oligomerization (but at maintained
large-scale colloidal stability) at high AMP loads, as well as remain-
ing negative z-potential at high peptide load for the presently
investigated poly(ethyl acrylate-co-methacrylic acid) microgels.
Although the underlying mechanisms behind these differences
are difficult to pin-point due to the lack of more systematic studies
of peptide loading, detailed studies of particle size distributions,
and membrane interactions for the previously reported novo-
cidin/hyaluronic acid microgel study, these likely relate to the
higher charge density and smaller persistence length of poly(ethyl
acrylate-co-methacrylic acid) compared to hyaluronic acid, allow-
ing the formation of dangling tails at the microgel surface.
Somewhat related, Silva et al. investigated loading of LLKKK18
(KEFKRIVKRIKKFLRKLV) into hyaluronic acid microgels in an effort
to reach efficient anti-tuberculosis effects [25]. Peptide incorpora-
tion into the hyaluronic acid microgels was found to result in
increased peptide stability, as also demonstrated in the present
investigation for LL-37 loaded onto MAA60 microgels, and reducedTable 1
Minimal inhibitory concentration (MIC; µM) for free DPK-060 as well as microgel-loaded
MIC (µM) MRSA E
DPK-060 1.6 3
MAA26.5 + DPK-060 0.8–1.6 1
MAA60 + DPK-060 3.2 6
LL-37 1.8–3.6 3
MAA26.5 + LL-37 >7.1 >
MAA60 + LL-37 >7.1 >
AP114 4 –
MAA26.5 + AP114 2–4 –
a Microgel without peptide displays no detectable antimicrobial effect up to at least 1cytotoxicity, again in line with findings for LL-37. Importantly,
Silva et al. also found microgels to be effectively internalized by
macrophages, and the microgel-loaded peptide to co-localize with
mycobacteria within host cells. This resulted in a significant reduc-
tion of the mycobacterial load in macrophages infected with either
Mycobacterium avium (M. avium) or Mycobacterium tuberculosis (M.
tuberculosis), mirrored by lowered pro-inflammatory cytokine (IL-6
and TNF-a) levels. In vivo, intra-tracheal administration of peptide-
loaded microgels significantly reduced infection levels in mice
challenged by M. avium or M. tuberculosis after just 5 or 10 every
other day administrations [25].
From a mechanistic perspective, a number of interesting effects
can be noted from both these previous and the present investiga-
tion. Notably, microgels offer opportunities for reaching very high
peptide loading, thereby protecting incorporated peptides from
proteolytic degradation, depending on the microgel charge densi-
ties, and without suffering from large-scale colloidal destabiliza-
tion. Having said that, the factors determining AMP loading seem
to be complex. For example, while increasing microgel net charge
increases the driving force for peptide incorporation, peptide bind-
ing causes the microgel particles to de-swell osmotically from the
surface inwards. In case of too strong peptide-microgel charge con-
trast, or in the presence of additional strong interactions (e.g.,
hydrophobic), this de-swelling front can move faster than peptide
diffusion, in turn resulting in the formation of a compact shell
around each microgel particle [46,41,51]. Such effects have previ-
ously been investigated in some detail for larger microgels through
confocal microscopy, but are considerably more challenging to
monitor directly for microgels as small as those investigated in
the present study. Although oligomerization may occur after pep-
tide loading (Fig. S1), peptide-loaded microgels obtain zero charge
only at very high peptide concentrations. Correspondingly, initial
peptide release, occurring from the outer regions of the microgels,
will result in rapid negative zeta poteintial growth of the partially
loaded microgels, reducing any tendency of aggregation.
Aggregation-induced peptide release is therefore unlikely as a pep-
tide release mechanism in these systems. However, as demon-
strated for LL-37, AMPs incorporated into oppositely charged
microgels may undergo dramatic conformational changes, likely
to affect peptide packing, loading capacity, and subsequent release
rate. In analogy to findings for larger microgels, the effect of micro-
gel loading on proteolytic stabilization of incorporated AMPs may
depend on microgel charge density (as observed also in the present
investigation) also in the absence of shell formation due to tighter
peptide binding to the microgel chains, thus precluding access to
these also for proteases able to enter into the microgels [48]. Thus,
further studies are needed to clarify the details of peptide confor-
mation, as well as radial peptide distribution within the microgel
particles, and how this translates into peptide release rate, mem-
brane interactions, and antimicrobial effects. Having said that, it
seems clear that peptide release is required for membrane destabi-
lization and antimicrobial effects of anionic microgels, a process
suppressed at high microgel charge contrast, as well as for longerpeptides against MRSA, E. coli, and two P. aeruginosa (PSA) strains.a
. coli PSA clin PSA ATCC
.2 6.4 3.2
.6–3.2 0.8 0.8
.4 6.4 3.2
.6 1.8–3.6 1.8–3.6
7.1 >7.1 7.1
7.1 >7.1 >7.1
– –
– –
00 ppm.
Fig. 9. Effect of microgels, peptides, and peptide-loaded microgels on hemolysis. (a)
Hemolysis as a function of microgel (MAA26.5 and MAA60) concentration,
performed in 5% PBS, pH 7.4. (b) Hemolysis as a function of LL-37 and DPK-060
concentration with or without 100 ppmmicrogels MAA26.5 and MAA60, performed
in Tris (10 mM pH 7.4) [52].
Fig. 10. Ratio intact LL-37 peptide before (wo.) and after (w.) treatment with
pseudomonas elastase (PE). Loading the peptide onto microgels does not in itself
affect the peptide structure.
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[43], moderating this in an effort to increase release rate and
antimicrobial effects may therefore come at a price of reduced pep-
tide loading capacity. As an alternative approach, biodegradable
microgels may offer interesting opportunities in cases where
biodegradation can be designed to be slow during storage, but fast
or triggered after administration [49].
5. Conclusions
Anionic poly(ethyl acrylate-co-methacrylic acid) microgels are
able to incorporate considerable amounts of the cationic AMPs
LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) and DPK-060 (GKHKNKGKKNGKHNGWKWWW), the peptides residing pri-
marily inside the microgels, as evidenced by z-potential measure-
ments. As a result of this, incorporated peptides can be protected
from degradation by infection-related proteases at high microgel
charge densities. Furthermore, as a result of net negative z-
potential, also at high peptide load, neither empty nor peptide-
loaded microgels adsorb at bacteria-mimicking lipid membranes.
Instead, membrane disruption is mediated almost exclusively by
peptide release. Analogously, antimicrobial effects require peptide
release, and are thus promoted by decreasing peptide length and
decreasing microgel charge density. Taken together, the results
provide some new insight on microgels as peptide delivery sys-
tems [19] through the correlation between peptide loading/release,
membrane interactions of void and peptide-loaded microgels, and
functional consequences of this in terms of antimicrobial effect,
toxicity, and protection from proteolytic degradation.
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